AI & ChatGPT searches , social queriess for SUNOVION
Search references for SUNOVION. Phrases containing SUNOVION
See searches and references containing SUNOVION!
Search references for SUNOVION. Phrases containing SUNOVION
See searches and references containing SUNOVION!SUNOVION
Pharmaceutical company
On July 1, 2023, Sunovion Pharmaceuticals Inc. became part of Sumitomo Pharma America, Inc., a biopharmaceutical company focused on delivering therapeutic
Sunovion
Investigational antipsychotic
medication was discovered in collaboration between PsychoGenics Inc. and Sunovion Pharmaceuticals (which was subsequently merged into Sumitomo Pharma) using
Ulotaront
Chemical compound
reuptake inhibitor (SNDRI) that was under development by Sunovion for the treatment of attention-deficit hyperactivity disorder (ADHD) and
Dasotraline
Pharmaceutical company based in Japan
for $2.6B in 2009, renaming its new stand-alone subsidiary Sunovion in 2010. Under Sunovion management, Sumitomo Dainippon Pharma was able to successfully
Sumitomo_Pharma
Combination drug
its U.S. commercial rights for Seebri Neohaler and Utibron Neohaler to Sunovion Pharmaceuticals. "Product monograph brand safety updates". Health Canada
Indacaterol/glycopyrronium bromide
Indacaterol/glycopyrronium_bromide
Atypical antipsychotic medication
Lurasidone was developed by Sunovion Pharmaceuticals, a division of Dainippon Sumitomo Pharma Co. of Japan. In 2009, Sunovion decided to develop lurasidone
Lurasidone
changed their name to Cynapsus Therapeutics in 2010. In September 2016, Sunovion (a subsidiary of Dainippon Sumitomo Pharma) announced it would acquire
Cynapsus_Therapeutics
(2000– ) Cybin (2019- ) Cyclacel (1997– ) Cynapsus (1984- ; acquired by Sunovion) Cytokinetics (1997– ) CytRx (1985– ) Daewoong (1945– ) Daiichi Sankyo
List of pharmaceutical companies
List_of_pharmaceutical_companies
Class of G protein-coupled receptors
PMID 35047111. "Sunovion: creating therapies to help transform people's lives". www.sunovion.com. Retrieved 4 June 2022. "Sunovion and PsychoGenics Announce
Trace amine-associated receptor
Trace_amine-associated_receptor
Class of drugs
Liming Shao, et al. WO2007081542 (Sunovion Pharmaceuticals Inc). Liming Shao & Jianguo Ma, WO2010091268 (Sunovion Pharmaceuticals Inc). Heike Radeke
Serotonin–norepinephrine–dopamine reuptake inhibitor
Serotonin–norepinephrine–dopamine_reuptake_inhibitor
Class of medications
Wyeth Lurasidone Benzisothiazole Atypical Latuda 2010 Sumitomo Dainippon/Sunovion Melperone Butyrophenone Disputed Buronil 1967 Lundbeck Mesoridazine
Antipsychotic
Professional organization of US psychiatrists
Lundbeck Myriad Genetics Neurocrine Biosciences Otsuka Pharmaceutical Pfizer Sunovion Takeda Pharmaceutical Company Donors to the foundation in 2019 include
American Psychiatric Association
American_Psychiatric_Association
Chemical compound
Novartis licensed its U.S. commercial rights for Arcapta Neohaler to Sunovion Pharmaceuticals. Substituted 2-aminoindane "Arcapta Neohaler (indacaterol)
Indacaterol
Atypical antipsychotic and antiemetic medication
ratio of its (R)- and (S)-enantiomers), is or was under development by Sunovion Pharmaceuticals for the treatment of bipolar depression in the United States
Amisulpride
Health industry trade group
healthcare investigators to collect medical quality data for research. In 2017, Sunovion used Embrace in a phase 4 clinical study of Aptiom, a drug meant to reduce
Empatica
American psychiatrist
Schizophrenia with Dr. Stephen M. Stahl, University of Bristol" (PDF). Sunovion Pharmaceuticals Europe Ltd. 2015. "Honorary Doctorate Title presented to
Stephen_Stahl
Anticonvulsant medication
but was marketed only under the first name. In the US it is marketed by Sunovion (formerly Sepracor) and was approved in November 2013. In May 2025, the
Eslicarbazepine_acetate
American nonprofit organization
Biosciences NeuroStar Northrop Grumman Novo Nordisk Otsuka Pharmaceutical Pfizer Sunovion Takeda Pharmaceutical Company Teva Pharmaceuticals The 2017 annual report
National Alliance on Mental Illness
National_Alliance_on_Mental_Illness
Medical doctor in the United States of America
Executive Medical Director and Head of the Medical Science Liaison Group at Sunovion Pharmaceuticals, Inc. in Marlborough, Massachusetts. In 2013 Herman took
Barry_K._Herman
Pharmaceutical company headquartered in Portugal
distribute it as Zebinix or Exalief in Europe. In America, it is marketed by Sunovion under the name Aptiom. Its use in epilepsy treatment in children is under
Bial
Stimulant drug
cycloalkylamines as monoamine reuptake inhibitors", published 2017-06-28, assigned to Sunovion Pharmaceuticals Inc. Lomenzo SA, Rhoden JB, Izenwasser S, Wade D, Kopajtic
(+)-CPCA
American psychologist
Neurolifesciences Neurovance Novartis Noven OnDosis Otsuka Pfizer Rhodes Shire Sunovion Takeda Sky Therapeutics Psyon Johnson & Johnson/Kenvue Vallon With his
Stephen_Faraone
Canadian not-for-profit organization
Sanofi Aventis Sanofi Pasteur Seagen Servier Shire Sobi Stallergenes Greer Sunovion Syneos Health Takeda Pharmaceutical Company TBWA Worldwide Teva Pharmaceuticals
Pharmaceutical Advertising Advisory Board
Pharmaceutical_Advertising_Advisory_Board
Canadian psychiatrist and academic
National Brain Disorders Prize, University of British Columbia 2020 Sumitomo/Sunovion Brain Health Clinical Research Award, CINP 2020 Colvin Prize in Mood Disorders
Gustavo_Turecki
Association of pharmaceutical companies
Roche Ropack Pharma Solutions Sanofi Santen Pharmaceutical Servier Sobi Sunovion Takeda Pharmaceutical Company Theratechnologies Valeo Pharma Vantage Biotrials
Innovative_Medicines_Canada
Spanish psychiatrist
International College of Neuropsychopharmacology with the CINP Sumitomo/Sunovion Brain Health Clinical Research Award. Dr. Arango is a past president of
Celso_Arango
Romanian-American scientist
(2024) Knight of the Order of Merit, The Chancery of Orders (2023) Sumitomo/Sunovion Prize, International College of Neuropsychopharmacology (2023) Doctor Honoris
Sergiu_P._Pașca
Dainippon Sumitomo Pharma purchased Sepracor, which currently operates as Sunovion, Inc. Biomembrane-mediated cell adhesion and transport: Quinn later returned
John_A._Quinn
Neuroscientist and psychiatrist exploring effects of cannabis use
2022 International College of Neuropsychopharmacology (CINP) - Sumimoto/Sunovion Brain Health Basic Research Award 2020 McGill Principal's prize for public
Gabriella_Gobbi
Canadian medical specialty organization
CFID include AbbVie, BD, BioMérieux, Gilead Sciences, KPMG, Merck, and Sunovion. AMMI Canada's principal event is the AMMI Canada-CACMID Annual Conference
Association of Medical Microbiology and Infectious Disease Canada
Association_of_Medical_Microbiology_and_Infectious_Disease_Canada
SUNOVION
SUNOVION
SUNOVION
SUNOVION
Male
Hebrew
(חֲדַד) Hebrew name CHADAD means "mighty" or "sharpness." In the bible, this is the name of one of the twelve sons of Ishmael. Also spelled Hadad.
Boy/Male
Tamil
Sunny, A bird
Boy/Male
Hindu, Indian
Lord Shiva
Girl/Female
Hebrew, Hindu, Indian
Protected; Shelter
Boy/Male
Hindu, Indian
Secret
Boy/Male
Tamil
Virtuous
Girl/Female
Hindu, Indian
Sung Beautifully
Boy/Male
Irish
Hero.
Male
English
Masculine variant spelling of English unisex Greer, GRIER means "watchful; vigilant."
Girl/Female
Gujarati, Hindu, Indian, Kannada
Love; Beloved; Loving; God's Gift
SUNOVION
SUNOVION
SUNOVION
SUNOVION
SUNOVION